3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow gimsilumab: new trials by email Literature Review of gimsilumab trials Research Report on gimsilumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) Gimsilumab, Placebo - COVID-19 | Phase 2 | Completed | Kinevant Sciences GmbH | 227 | 2020-04-15 | 2021-12-14 |
| Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis KIN-1901, Placebo - Inflammation, Rheumatic Diseases | Phase 1 | Completed | Kinevant Sciences GmbH | 36 | 2019-11-12 | 2020-04-13 |
| Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects MORAb-022 - Rheumatoid Arthritis | Phase 1 | Completed | Morphotek | 20 | 2013-05-01 | 2015-11-16 |
Arthritis, Rheumatoid (1) · COVID-19 (1) · Coronavirus Infections (1) · Cytokine Release Syndrome (1) · Inflammation (1) · Lung Injury (1) · Rheumatic Diseases (1) · Severe Acute Respiratory Syndrome (1) · Spondylitis, Ankylosing (1)
Kinevant Sciences GmbH (2) · Morphotek (1)
United States (2) · Canada (1) · Netherlands (1)
Alan J. Kivitz, MD, CPI (1) · Chrysoula Pappa, MD (1) · Lydie Hazan, MD (1) · William M Schnitz, MD (1)